Lucent, Inc., a Wholly-Owned Subsidiary of Tipmefast, Inc., Announces Acquisition to Further its Technology Expansion
09 oct. 2024 08h30 HE
|
Tipmefast, Inc.
Santa Ana, CA., Oct. 09, 2024 (GLOBE NEWSWIRE) -- Tipmefast, Inc. (OTC: TMEF) today announced that Lucent, Inc. (“Lucent” or the “Company”), its wholly owned subsidiary, continues to expand its role...
Kaiterra Unveils Sensedge Go, a Revolutionary Wireless Air Quality Monitor with the Longest Battery Life on the Market
20 sept. 2024 08h00 HE
|
Kaiterra
San Francisco, CA, Sept. 20, 2024 (GLOBE NEWSWIRE) -- Kaiterra, a global leader in cutting-edge air quality monitoring solutions, announced today the launch of the Sensedge Go. This groundbreaking...
Kaiterra Unveils Sensedge Go, a Revolutionary Wireless Air Quality Monitor with the Longest Battery Life on the Market
18 sept. 2024 08h00 HE
|
Kaiterra
San Francisco, CA, Sept. 18, 2024 (GLOBE NEWSWIRE) -- Kaiterra, a global leader in cutting-edge air quality monitoring solutions, announced today the launch of the Sensedge Go. This groundbreaking...
Gastroenterologists Slow to Adopt Eli Lilly’s Omvoh, Pfizer’s Velsipity, and Takeda’s subcutaneous formulation of Entyvio for the Treatment of Ulcerative Colitis, but Future Projections Reveal a Highly Evolving Market
22 mars 2024 10h14 HE
|
Spherix Global Insights
Exton, Pennsylvania, March 22, 2024 (GLOBE NEWSWIRE) -- The end of 2023 introduced several new treatment options for patients suffering from ulcerative colitis (UC). Among them is Eli Lilly’s Omvoh...
Mullen Emphasizes Focus on Commercial Vehicle Segment with First Mover Advantage Across Class 1 and 3 Electric Cargo Vans and Trucks
26 févr. 2024 10h00 HE
|
Mullen Automotive, Inc.
Company in full commercial EV production with Class 1 and Class 3 vehicles; Bollinger Motors focused on Class 4-6 vehicles with Class 4 production starting in second half 2024 Company achieves...
Bristol Myers Squibb Adds Premier Radiopharmaceutical Platform with Acquisition of RayzeBio
26 déc. 2023 07h13 HE
|
Rayzebio, Inc.
Transaction Brings RayzeBio’s Differentiated Actinium-Based Radiopharmaceutical Platform, Including Rich Pipeline of Multiple Drug Development Programs to Bristol Myers Squibb’s Leading Oncology...
BMS Attributes Sotyktu Falling Short of Growth Expectations to Access, but Recent Spherix Global Insights’ Data Suggest Safety Concerns Are More of a Barrier to Increased Uptake
07 déc. 2023 12h01 HE
|
Spherix Global Insights
Exton, PA, Dec. 07, 2023 (GLOBE NEWSWIRE) -- While access took the forefront of BMS’ response to Sotyktu (deucravacitinib) not meeting growth expectations during the company’s Q3 earnings call,...
Eli Lilly's Olumiant and Pfizer's Litfulo Strengthen Alopecia Areata Arsenal, Yet Resounding Opportunity for JAK Expansion and New Assets in Development Remain
15 nov. 2023 11h22 HE
|
Spherix Global Insights
Exton, Pennsylvania, Nov. 15, 2023 (GLOBE NEWSWIRE) -- Spherix Global Insights has been monitoring the alopecia areata (AA) market for the past four years and has found that the entry of JAK...
An Old Dog with a New Trick… Ellodi’s APT-1011 Promises EoE Patients a Convenient and Potent Treatment Alternative
15 août 2023 15h40 HE
|
Spherix Global Insights
Exton, Pennsylvania, Aug. 15, 2023 (GLOBE NEWSWIRE) -- Since launching in May 2022, Sanofi/Regeneron’s Dupixent has been well received by gastroenterologists and allergists as an advancement for...
Immatics Announces $35 Million Equity Investment from Bristol Myers Squibb
24 juil. 2023 07h00 HE
|
https://immatics.com/
Tuebingen, Germany and Houston, TX, July 24, 2023 – Immatics N.V. (NASDAQ: IMTX, “Immatics”), a clinical-stage biopharmaceutical company active in the discovery and development of T cell-redirecting...